{"id":"NCT04657016","sponsor":"Eli Lilly and Company","briefTitle":"A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program","officialTitle":"Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo After an Intensive Lifestyle Program in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double Blind, Placebo-Controlled Trial (SURMOUNT-3)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2021-03-29","primaryCompletion":"2023-04-20","completion":"2023-05-12","firstPosted":"2020-12-07","resultsPosted":"2024-05-16","lastUpdate":"2024-05-16"},"enrollment":579,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Obesity","Overweight"],"interventions":[{"type":"DRUG","name":"Tirzepatide","otherNames":["LY3298176"]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"Tirzepatide","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a study of tirzepatide in participants with obesity. The purpose of this study is to learn more about how tirzepatide maintains body weight or adds to weight loss after an intensive lifestyle modification program. The study will last about 2 years (29 visits).","primaryOutcome":{"measure":"Percent Change From Baseline in Body Weight","timeFrame":"Baseline, 72 Weeks","effectByArm":[{"arm":"Placebo","deltaMin":3.3,"sd":0.6},{"arm":"Tirzepatide","deltaMin":-21.1,"sd":0.59}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":7},"locations":{"siteCount":65,"countries":["United States","Argentina","Brazil","Puerto Rico"]},"refs":{"pmids":["40717199","37840095"],"seeAlso":["https://trials.lillytrialguide.com/en-US/trial/1ZuH7WHjpse8JDpVFSSi1I"]},"adverseEventsSummary":{"seriousAny":{"events":14,"n":292},"commonTop":["Nausea","Covid-19","Diarrhoea","Constipation","Vomiting"]}}